AASB Dialogue Series – R&D Reporting under IFRS: Evidence, Insights and Implications

Register Here

26 May, 4:00 pm — 5:15 pm (AEST)

Join us for an insightful webinar on the latest evidence in R&D (Research and Development) reporting under IFRS. The session explores how R&D is recognised and disclosed, why it matters to investors and how it informs real‑world decisions.

Drawing on recent research and practical insights, the session will highlight key implications for preparers seeking more transparent and decision‑useful R&D reporting.

Featuring: Amir Ghandar, Jeffrey Hales, Moana Overton, Ram Subramanian, Yannis Tsalavoutas, Fanis Tsoligkas, and Rachel Waterhouse.